Calprotectin is not independent from baseline erosion in predicting radiological progression in early rheumatoid arthritis. Comment on 'Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis' by Jonsson et al

Ann Rheum Dis. 2018 Dec;77(12):e84. doi: 10.1136/annrheumdis-2017-212816. Epub 2018 Jan 10.

Maxime Chevreau¹, Marie-Hélène Paclet^{2

3}, Xavier Romand^{1

2}, Jean-Louis Quesada^{4

5}, Olivier Vittecoq⁶, Philippe Dieudé⁷, Bertrand Toussaint⁸, Philippe Gaudin^{1

2}, Athan Baillet^{1

2}

¹ Department of Rheumatology, Grenoble Alpes University Hospital, Grenoble, France.
² Univ Grenoble Alpes, GREPI-UGA EA7408, Grenoble, France.
³ Lab. Biochimie des Enzymes et des Protéines, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France.
⁴ INSERM, Clinical Investigation Center CIC P 1406, Grenoble Alpes University Hospital, Grenoble, France.
⁵ Scientific Department of the Clinical Research Delegation, Grenoble Alpes University Hospital, Grenoble, France.
⁶ Department of Rheumatology, Rouen Hospital, Bois-Guillaume, France.
⁷ Department of Rheumatology, Bichat Hospital, Paris, France.
⁸ Laboratoire TIMC-IMAG-TheREx, UMR 5525 Centre National de la Recherche Scientifique, Univ Grenoble Alpes, Grenoble, France.

No abstract available

Keywords: arthritis; early rheumatoid arthritis; outcomes research.

Publication types